Immunicum holds a Scientific Advice Meeting

• 10:45

Immunicum holds a Scientific Advice Meeting with the Medical Products Agency to discuss the upcoming clinical phase I/II trial in renal cell carcinoma and considers the conditions for initiating the trial to be very favorable.

Comments are closed.